papaverine has been researched along with glyburide in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Sen, S; Sinha, N | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hatake, K; Hishida, S; Wakabayashi, I | 1 |
| Halama, A; Korolkiewicz, KZ; Korolkiewicz, R; Rekowski, P; Sliwiński, W | 1 |
| Faraci, FM; Sobey, CG | 2 |
| Deka, DK; Mishra, SK; Raviprakash, V | 1 |
| García de Boto, MJ; Hidalgo, A; Martínez, C; Sánchez, M | 1 |
| Bosnjak, JJ; Gutterman, DD; Miura, H; Miura, M; Ning, G; Saito, T | 1 |
| Clancy, JP; Cobb, BR; Fan, L; Kovacs, TE; Sorscher, EJ | 1 |
| Antunes, E; de Miranda Cará, A; De Nucci, G; Fregonesi, A; Rodrigues Netto, N | 1 |
| Fujimoto, S; Kunimatsu, M; Mori, M; Tsushima, H | 1 |
| Colantuoni, A; Lapi, D; Marchiafava, PL | 1 |
1 review(s) available for papaverine and glyburide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
19 other study(ies) available for papaverine and glyburide
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Endothelium-dependent relaxation resistant to NG-nitro-L-arginine in rat aorta.
Topics: Acetylcholine; Analysis of Variance; Animals; Aorta, Thoracic; Arginine; Atropine; Biological Factors; Cyclic GMP; Endothelium, Vascular; Glyburide; Indomethacin; Isometric Contraction; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroarginine; Norepinephrine; Oxyhemoglobins; Papaverine; Potassium Channel Blockers; Rats; Rats, Wistar; Tetraethylammonium; Tetraethylammonium Compounds | 1995 |
Actions of galanin and some of its analogues on rat isolated gastric fundus.
Topics: Analysis of Variance; Animals; Bucladesine; Calcium Channel Blockers; Dibenzylchlorethamine; Diltiazem; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Female; Galanin; Gastric Fundus; Glyburide; Lethal Dose 50; Male; Muscle Contraction; Muscle, Smooth; Papaverine; Parasympatholytics; Rats; Rats, Wistar; Substance P | 1996 |
Effect of nitric oxide and potassium channel agonists and inhibitors on basilar artery diameter.
Topics: Animals; Basilar Artery; Enzyme Inhibitors; Glyburide; Male; Nitric Oxide; Nitroarginine; Nitroprusside; Papaverine; Peptides; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; Tetraethylammonium; Tetraethylammonium Compounds; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1997 |
Basal nitric oxide release differentially modulates vasodilations by pinacidil and levcromakalim in goat coronary artery.
Topics: Animals; Coronary Vessels; Cromakalim; Endothelium, Vascular; Enzyme Inhibitors; Glyburide; Goats; Guanidines; Hypoglycemic Agents; In Vitro Techniques; Methylene Blue; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Papaverine; Pinacidil; Potassium Channels; Vasodilation; Vasodilator Agents | 1998 |
Inhibitory effect of 4-aminopyridine on responses of the basilar artery to nitric oxide.
Topics: 4-Aminopyridine; Acetylcholine; Adenosine Triphosphate; Animals; Basilar Artery; Cromakalim; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyburide; Guanylate Cyclase; Male; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Oxadiazoles; Papaverine; Potassium Channel Blockers; Quinoxalines; Rats; Rats, Sprague-Dawley; Vasodilation; Vasodilator Agents | 1999 |
Involvement of K(ATP) channels in diethylstilbestrol-induced relaxation in rat aorta.
Topics: Animals; Aorta; Colforsin; Cyclic AMP; Diazoxide; Diethylstilbestrol; Dose-Response Relationship, Drug; Eflornithine; Glyburide; In Vitro Techniques; Indoles; Male; Muscle, Smooth, Vascular; Norepinephrine; Papaverine; Potassium Channels; Rats; Rats, Wistar; Spermine; Tamoxifen; Tetraethylammonium; Vasoconstriction; Vasodilation; Vasodilator Agents | 2001 |
Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles.
Topics: Apamin; Arterioles; Catalase; Cerium; Coronary Vessels; Enzyme Inhibitors; Fluorescent Dyes; Glyburide; Humans; Hydrogen Peroxide; In Vitro Techniques; Iron Chelating Agents; Membrane Potentials; Microscopy, Confocal; Microscopy, Electron; Microscopy, Video; Muscle, Smooth, Vascular; Oxidants; Papaverine; Potassium Channel Blockers; Stress, Mechanical; Vasodilation; Vasodilator Agents | 2003 |
Adenosine receptors and phosphodiesterase inhibitors stimulate Cl- secretion in Calu-3 cells.
Topics: Adenosine Deaminase; Anions; Cell Line; Chlorine; Cilostazol; Colforsin; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Electrophysiology; Epithelium; Glyburide; Humans; Hypoglycemic Agents; Milrinone; Mutation; Papaverine; Phosphodiesterase Inhibitors; Piperazines; Purines; Receptors, Purinergic P1; Rolipram; Sildenafil Citrate; Sulfones; Tetrazoles; Time Factors | 2003 |
Role of adenosine triphosphate-dependent potassium channels in canine penile erection.
Topics: Adenosine Triphosphate; Animals; Arginine; Cromakalim; Dogs; Electric Stimulation; Glyburide; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Papaverine; Penile Erection; Potassium Channel Blockers; Potassium Channels; Pressure; Receptors, Drug | 2004 |
Capsaicin-induced, capsazepine-insensitive relaxation of the guinea-pig ileum.
Topics: 4-Aminopyridine; Acetylcholine; Animals; Apamin; Barium; Benzopyrans; Caffeine; Calcitonin Gene-Related Peptide; Calcium; Capsaicin; Charybdotoxin; Diclofenac; Dimethyl Sulfoxide; Diterpenes; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyburide; Guanethidine; Guinea Pigs; Ileum; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Male; Muscle Relaxation; Muscle, Smooth; Myosin Light Chains; Nitroarginine; Papaverine; Peptide Fragments; Phosphodiesterase Inhibitors; Phosphorylation; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Chloride; Protein Serine-Threonine Kinases; Pyrazoles; Receptor, Cannabinoid, CB1; rho-Associated Kinases; Tetraethylammonium; Vasodilator Agents | 2006 |
Pial microvascular responses to transient bilateral common carotid artery occlusion: effects of hypertonic glycerol.
Topics: Animals; Blood Flow Velocity; Capillary Permeability; Carotid Artery, Common; Carotid Stenosis; Cell Adhesion; Cerebrovascular Circulation; Chemotaxis, Leukocyte; Disease Models, Animal; Glyburide; Glycerol; Hypertonic Solutions; Infusions, Intravenous; KATP Channels; Ligation; Male; Microcirculation; Microscopy, Fluorescence; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Papaverine; Pia Mater; Potassium Channel Blockers; Rats; Rats, Wistar; Regional Blood Flow; Vasodilation; Vasodilator Agents | 2008 |